Les victimes d'effets indésirables graves de médicaments continuent à éprouver de grandes difficultés à être reconnues comme telles. Il est temps d'agir. https://t.co/vo7kacDnaq
Après les scandales du Mediator ou du vaccin DT Polio de Sanofi, la Cour de cassation soigne les victimes de médocs. Les malades auront désormais dix ans pour agir en justice, contre trois initialement. Une pilule dure à avaler pour Big Pharma !
➡️ https://t.co/Tpwe6OBCXa
Marketing isomers: a potentially harmful optical illusion, leading to dosing errors when both the enantiomer and the racemate are available on the market
Insulin-related errors in computer entry can be due to confusion between brand names, or inappropriate prescription or dispensing software, or confusion between %s of insulin in the brand name and the dose. A long-standing observation @PrescrireInt
https://t.co/RPGJOad0gm
The International Medication Safety Network also mourns the death of David Cousins. Paying him the tribute he deserves, prominently displayed on https://t.co/ufRrv3U2Ml, we can measure the extent of his contribution to numerous advances in the prevention of medication errors
See also the position statement issued by the International Medication Safety Network @intmedsafe calling for greater worldwide attention to the problem of unsafe design of vaccine packaging and labelling https://t.co/0Oki3NNs6J
Une réelle avancée en l'absence d'incitation, relevée par Prescrire dans "Enfin un référentiel de "bonnes pratiques" de dispensation à l'officine" Rev Prescrire 2017 ; 37 (406) : 575-576.
Drug shortages result in substandard care and adverse events, sometimes causing serious harm, particularly with cytotoxic drugs. Errors, some of which were fatal, occur when a different product is provided to replace the unobtainable product @PrescrireInt https://t.co/1xbrnkU1jb
Lithium needs to be carefully dosed since there is a very narrow margin between the therapeutic dose and the appearance of sometimes severe adverse effects https://t.co/MDe7C38V6U @PrescrireInt
Choosing quality packaging for safer care. In 2021, Prescrire analysed 190 drug packages: there were a few signs of progress, but all too often, it is not until errors are reported to the agencies after marketing that a package is finally improved @PrescrireInt
A particulary useful source on medication safety and proactive arguments for preventing medication errors @PrescrireInt Have a look too on the publications issued by the International Medication Safety Network IMSN members https://t.co/Ed9qDmpoRu
⚠️ Risque de surdosage à la #vitamineD chez les enfants.
Nous rappelons nos recos :
✅préférer les médicaments aux compléments alimentaires,
✅contrôler les doses administrées,
❎ne pas multiplier les produits contenant de la vitamine D.
Plus d'infos : https://t.co/J6ovGuyTMe
Capsaicin: allergy in healthcare professionals. When applying and removing patches, patients and caregivers are exposed to airborne capsaicin: one more reason to keep them out of care. Prescrire International 2022; 31 (235) 76. @PrescrireInt
Rivaroxaban is the first oral factor Xa inhibitor to be granted marketing authorisation in the European Union for use in children and adolescents. In this situation, what benefit does rivaroxaban bring, compared to a heparin derivative or warfarin?
➡️ https://t.co/LAaDdfsavN
Fully supported since the December 2021 Revue Prescrire issue, translated in Prescrire International March 2022 issue https://t.co/K0P4f1IzwO "Confusing tranexamic acid for a local anaesthetic: fatal spinal injections" Prescrire International 2022;31(235):75-76.
📢 ALERT: Substitution Error with Tranexamic Acid during Spinal Anesthesia can lead to catastrophic patient harm.
Read this bulletin for a multi-pronged approach to prevent substitution errors and to optimize the safe use of tranexamic acid.
➡️ https://t.co/SKQsko22sd